Previous 10 | Next 10 |
2023-10-10 08:51:03 ET SMX (Security Matters) ( SMX ) +109% Secures Majority Stake in True Gold Consortium. Mobilicom Limited ( MOB ) +47% . AC Immune ( ACIU ) +15% . Immunic ( IMUX ) +14% jumps after the bell on positive int...
AC Immune to Present at the Jefferies 2023 CNS & Neuro Summit in October 2023 Lausanne, Switzerland, October 5, 2023 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that Co...
AC Immune to Present at the H.C. Wainwright 25th Annual Global Investment Conference in September 2023 Lausanne, Switzerland, September 05 , 202 3 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medici...
2023-08-04 07:59:55 ET AC Immune press release ( NASDAQ: ACIU ): Q2 GAAP EPS of -$0.20 beats by $0.02 . Cash position of CHF 93.0 million finances the Company into Q3 2024, excluding the benefit of anticipated milestone payments For further details see: AC Im...
AC Immune Reports Second Quarter 2023 Financial Results and Provides a Corporate Update Received FDA Fast Track Designation for ACI-24.060 anti-amyloid-beta (Abeta) active immunotherapy to treat Alzheimer’s disease (AD) Enrollment in ongoing Phase 1b/2 ABATE study o...
AC Immune to Present at the B TIG Virtual Biotechnology Conference 2023 Lausanne, Switzerland, July 28 , 202 3 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative disease...
2023-07-26 08:16:56 ET AC Immune ( NASDAQ: ACIU ) has announced the appointment of Nuno Mendonça as CMO and be appointed to the Executive Committee, effective Oct. 1st. Johannes Streffer, MD, currently CMO, will leave at the end of September to pursue a new role. ...
AC Immune SA Appoints New Chief Medical Officer Nuno Mendonça, MD appointed new Chief Medical Officer and Executive Committee member Lausanne, Switzerland, July 2 6 , 202 3 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmac...
AC Immune Showcas ing Precision Medicine P rograms at A AIC 202 3 Lausanne, Switzerland, Ju ly 3 , 202 3 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurode...
2023-06-30 15:13:07 ET Shares of AC Immune (NASDAQ: ACIU) were up more than 54% for the week as of 2:30 p.m. on Friday, after being up by as much as 60.5%, according to data provided by S&P Global Market Intelligence . The clinical-stage biotech company's stock closed la...
News, Short Squeeze, Breakout and More Instantly...
AC Immune Showcasing its Novel Morphomer-Antibody Drug Conjugate (morADC) Platform for the Treatment of Neurodegenerative Diseases at AAIC 2024 Three oral presentations at the Alzheimer’s Association International Conference (AAIC 2024), including talks on morADC, ACI-24.060,...
2024-05-30 18:30:02 ET BTIG analyst issues BUY recommendation for ACIU on May 30, 2024 04:49PM ET. ACIU was trading at $3.97 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Buy recommendations . ...
2024-05-30 18:00:07 ET Thomas Shrader from BTIG issued a price target of $8.00 for ACIU on 2024-05-30 16:49:00. The adjusted price target was set to $8.00. At the time of the announcement, ACIU was trading at $3.97. The overall price target consensus is at $10.00 with hi...